Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 19/20 | 0.51 |
| ▸ | CSNK2B | P67870 | 19/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 9/20 | 0.44 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30694765 | 0.90 | CSNK2A2 (0.51) | CSNK2A2CSNK2BCSNK2A1PIM1PIM2 | |
| SCHEMBL25371037 | 0.90 | CSNK2A2 (0.51) | CSNK2A2CSNK2BCSNK2A1PIM1PIM2 | |
| SCHEMBL26048832 | 0.89 | CSNK2A2 (0.53) | CSNK2A2CSNK2BCSNK2A1PIM1PIM2 | |
| SCHEMBL25370631 | 0.89 | CSNK2A2 (0.50) | CSNK2A2CSNK2BCSNK2A1PIM1PIM2 | |
| SCHEMBL30694781 | 0.83 | PARP1 (0.54) | CSNK2A2CSNK2BCSNK2A1PARP1 | |
| SCHEMBL25370051 | 0.83 | PARP1 (0.54) | CSNK2A2CSNK2BCSNK2A1PARP1 | |
| SCHEMBL26049067 | 0.81 | CSNK2A2 (0.43) | CSNK2A2CSNK2BCSNK2A1PIM1PIM2 | |
| SCHEMBL26049275 | 0.81 | STING1 (0.48) | CSNK2A2CSNK2BCSNK2A1PIM1PIM2 | |
| SCHEMBL26048829 | 0.81 | CSNK2A2 (0.56) | CSNK2A2CSNK2BCSNK2A1PARP1 | |
| SCHEMBL26048836 | 0.80 | CSNK2A2 (0.53) | CSNK2A2CSNK2BCSNK2A1PARP1CSNK2A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295736-A | Benzo [ C ] [2,6] naphthyridine derivatives, compositions thereof and therapeutic uses thereof | 剑桥实业有限公司 | 2023-12-26 | — | — | CN | disclosed |